Precision medicine in low-income settings and small island developing states

Ashley, E. A. Towards precision medicine. Nat. Rev. Genet. 17, 507–522 (2016).

Article  CAS  PubMed  Google Scholar 

Lu, C. Y., Terry, V. & Thomas, D. M. Precision medicine: affording the successes of science. npj Precis. Onc. 7, 3 (2023).

Article  Google Scholar 

Edvardsson, M. & Heenkenda, M. K. Precision medicine: personalizing healthcare by bridging aging, genetics, and global diversity. Healthcare 13, 1529 (2025).

Article  PubMed  PubMed Central  Google Scholar 

Delpierre, C. & Lefèvre, T. Precision and personalized medicine: what their current definition says and silences about the model of health they promote. Implication for the development of personalized health. Front. Sociol. 8, 1112159 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Misra, S. et al. The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries. Lancet Diabetes Endocrinol. 11, 836–847 (2023).

Article  PubMed  Google Scholar 

De Oliveira, L. et al. Creating biobanks in low and middle-income countries to improve knowledge - the PREPARE initiative. Pregnancy Hypertens. 13, 62–64 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Artene, S.-A. et al. Biobanking in a constantly developing medical world. ScientificWorldJournal 2013, 343275 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Abdelhafiz, A. S. et al. Biobanks in the low- and middle-income countries of the Arab Middle East region: challenges, ethical issues, and governance arrangements-a qualitative study involving biobank managers. BMC Med. Ethics 23, 83 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Ezzat, S., Biga, R. & Kozlakidis, Z. Biobanking in LMIC settings for infectious diseases: challenges and enablers. Biosaf. Health 4, 290–292 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Miranda, J. J. et al. Understanding the rise of cardiometabolic diseases in low- and middle-income countries. Nat. Med. 25, 1667–1679 (2019).

Article  CAS  PubMed  Google Scholar 

Gaziano, T. A., Bitton, A., Anand, S., Abrahams-Gessel, S. & Murphy, A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr. Probl. Cardiol. 35, 72–115 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Zhang, X. et al. Cardiovascular disease prevention and mortality across 1 million urban populations in China: data from a nationwide population-based study. Lancet Public Health 7, e1041–e1050 (2022).

Article  PubMed  Google Scholar 

Bernabe-Ortiz, A. & Carrillo-Larco, R. M. Urbanization, altitude and cardiovascular risk. Glob. Heart 17, 42 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Dutta, N. & Dhar, D. Understanding medical technology innovation in low- and middle-income countries: factors, impact, and a model proposal. She Ji: J. Des. Econ. Innov. 10, 192–222 (2024).

Google Scholar 

Pantoja, T. et al. Implementation strategies for health systems in low-income countries: an overview of systematic reviews. Cochrane Database Syst. Rev. 2017, CD011086 (2017).

Google Scholar 

Zyl, C. van, Badenhorst, M., Hanekom, S. & Heine, M. Unravelling ‘low-resource settings’: a systematic scoping review with qualitative content analysis. BMJ Glob. Health 6, e005190 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Miller, D. M., McCauley, K. F. & Dunham-Snary, K. J. Metabolic dysfunction-associated steatotic liver disease (MASLD): mechanisms, clinical implications and therapeutic advances. Endocrinol. Diabetes Metab. 8, e70132 (2025).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chew, N. W. S. et al. Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified delphi approach. Circulation 151, 98–119 (2025).

Article  PubMed  Google Scholar 

UNIDO and Small Island Developing States (SIDS). UNIDO https://www.unido.org/sites/default/files/files/2020-04/GC.18_CRP.05_UNIDO_s_Small_Island_Developing_States_Strategy_2019%E2%80%932025.pdf (2021).

Office of the High Representative for the Least Developed Countries, Landlocked Developing Countries and Small Island Developing States. About small island developing states. UN https://www.un.org/ohrlls/content/about-small-island-developing-states (2026).

Office of the High Representative for the Least Developed Countries, Landlocked Developing Countries and Small Island Developing States. List of SIDS. UN https://www.un.org/ohrlls/content/list-sids (2026).

Rosin, R. D. et al. Evaluation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection and follow-up in a Caribbean population. Cancer Epidemiol. 92, 102642 (2024).

Article  PubMed  Google Scholar 

Cefalu, W. T. et al. A global initiative to deliver precision health in diabetes. Nat. Med. 30, 1819–1822 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

What will it take to make precision health a global reality. Nat. Med. 30, 1793–1794 (2024).

Anaya, J.-M., Herrán, M. & Pino, L. E. Challenges and opportunities for precision medicine in developing nations. Expert Rev. Precis. Med. Drug Dev. 10, 1–15 (2025).

Article  Google Scholar 

Radich, J. P. et al. Precision medicine in low- and middle-income countries. Annu. Rev. Pathol. 17, 387–402 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ouma, L. O. et al. Master protocols in low- and middle-income countries: a review of current use, limitations and opportunities for precision medicine. BMJ Glob. Health 10, e018561 (2025).

Article  PubMed  PubMed Central  Google Scholar 

Taylor, S. The vulnerability of health infrastructure to the impacts of climate change and sea level rise in small island countries in the South Pacific. Health Serv. Insights 14, 11786329211020857 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Meessen, B. et al. When one size does not fit all: aid and health system strengthening for small island developing states. Health Policy Plan. 39, i4–i8 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Nonić, M. & Šijačić-Nikolić, M. in Life on Land (eds Leal Filho, W., Azul, A. M., Brandli, L., Özuyar, P. G. & Wall, T.) (Springer, 2019). https://doi.org/10.1007/978-3-319-71065-5_53-1.

Psychiatric Genomics Consortium. The importance of studying many populations in genetic research. PGC https://pgc.unc.edu/for-the-public/diversity-in-genetic-studies/ (2026).

Fatumo, S. et al. Diversity in genomic studies: a roadmap to address the imbalance. Nat. Med. 28, 243–250 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gouveia, M. H. et al. Unappreciated subcontinental admixture in Europeans and European Americans and implications for genetic epidemiology studies. Nat. Commun. 14, 6802 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamri, A. et al. The genetic risk of gestational diabetes in South Asian women. eLife 11, e81498 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salvatore, T. et al. Current knowledge on the pathophysiology of lean/normal-weight type 2 diabetes. Int. J. Mol. Sci. 24, 658 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Caleyachetty, R. et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol. 9, 419–426 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Loos, R. J. F. & Yeo, G. S. H. The bigger picture of FTO – the first GWAS-identified obesity gene. Nat. Rev. Endocrinol. 10, 51–61 (2014).

Article  CAS  PubMed 

Comments (0)

No login
gif